Topical microbicides become topical.
Moore
John P
JP
Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, USA.
D000282:Administration, Intravaginal; D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D018946:Chemokine CCL5 / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D008253:Macaca mulatta; D016097:Simian Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D015302:Simian Immunodeficiency Virus / Q000187:drug effects
D019380:Anti-HIV Agents; D000891:Anti-Infective Agents, Local; D018946:Chemokine CCL5; C492865:RANTES, N(alpha)-(n-nonanoyl)-desSer(1)-(thioproline(2),cyclohexylglycine(3))-